Mutant sodium channel Nav1.7 and methods related thereto

Details for Australian Patent Application No. 2005207002 (hide)

Owner University of Utah Research Foundation

Inventors Singh, Nanda A.; Leppert, Mark F.

Agent Griffith Hack

Pub. Number AU-B-2005207002

PCT Pub. Number WO2005/069969

Priority 60/538,149 21.01.04 US

Filing date 21 January 2005

Wipo publication date 4 August 2005

Acceptance publication date 17 March 2011

International Classifications

C07K 14/00 (2006.01) Peptides having more than 20 amino acids

C07K 14/705 (2006.01) Peptides having more than 20 amino acids

C12N 5/10 (2006.01) Undifferentiated human, animal or plant cells, e.g. cell lines - Cells modified by introduction of foreign genetic material, e.g. virus-transformed cells

C12N 15/00 (2006.01) Mutation or genetic engineering

C12N 15/11 (2006.01) Mutation or genetic engineering - DNA or RNA fragments

C12N 15/63 (2006.01) Mutation or genetic engineering - Introduction of foreign genetic material using vectors

C12Q 1/68 (2006.01) Measuring or testing processes involving enzymes or micro-organisms - involving nucleic acids

Event Publications

10 August 2006 PCT application entered the National Phase

  PCT publication WO2005/069969 Priority application(s): WO2005/069969

17 March 2011 Application Accepted

  Published as AU-B-2005207002

14 July 2011 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005207003-Antibody specificity transfer using minimal essential binding determinants

2005206983-Micro-fluid ejection device having high resistance heater film